Business & Finance
Human genetics-focused biopharmaceutical company reports Q2 2005 results
Published in Gene Therapy Weekly, September 15th, 2005
Revenue for the second quarter 2005 was $11.4 million, compared to $9.6 million for the same period a year ago. For the first 6 months of 2005, revenue was $21 million, compared to $19.9 million for the first 6 months of 2004. At June 30, 2005, the company had $16.9 million in deferred research revenue, which will be recognized over future reporting periods.
Net loss for the second quarter 2005 was $13.3 million, unchanged from the second quarter 2004. For the 6 months of 2005, net loss was $30.3 million, compared to $25.3 million for the same period...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2005-09-15)
More Articles from Gene Therapy Weekly
- Arthritis Vaccine
Gene transfer to human joints accomplished - Congenital Heart Disease
Murine t-box transcription factor TBX20 mutation linked to cardiomyopathies - Cystic Fibrosis Therapy
Plasmid DNA vectors detected following gene transfer to murine airways - Proteomics
Researchers published expression system for NfdA studies - Virology Vaccine
QPCR used to assign infectious potencies to adenovirus-based vaccines - Bone Resorption
Researchers looking forward to new bone inhibitor development for study and use - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
